Mortality rates in patients with Barrett's oesophagus - PubMed (original) (raw)
Mortality rates in patients with Barrett's oesophagus
P Moayyedi et al. Aliment Pharmacol Ther. 2008.
Abstract
Background: Patients with Barrett's oesophagus are at increased risk of oesophageal adenocarcinoma. Observational studies have suggested increase in overall mortality also but data are conflicting.
Aim: To assess the cause of death in patients with Barrett's oesophagus compared with the general population.
Methods: Patients with Barrett's oesophagus were identified retrospectively in four hospitals in Leicestershire, UK using electronic endoscopy and histopathology records from 1997 to 2003. Data on deaths from this cohort of patients were identified through the Office of National Statistics and compared with age- and gender-adjusted mortality in the Leicestershire region.
Result: In all, 1272 Barrett's patients were identified with 245 deaths in this cohort. Overall mortality was found to be increased [male standardized mortality ratio (SMR) = 552, 95% CI = 466-638; female SMR 455, 95% CI = 357-552]. The main disease areas that were responsible for this increase were oesophageal adenocarcinoma (n = 25, male SMR = 2171, 95% CI = 991-3351; female SMR = 1300, 95% CI = 26-2574), bronchopneumonia (n = 70, male SMR = 146, 95% CI = 55-236; female SMR = 436, 95% CI = 272-601) and ischaemic heart disease (n = 51, male SMR = 186, 95% CI = 97-2748; female SMR = 205, 95% CI = 105-306).
Conclusions: Patients with Barrett's oesophagus die more commonly of bronchopneumonia and ischaemic heart disease compared with oesophageal adenocarcinoma, and overall mortality in this group may be increased.
Comment in
- Mortality risks associated with Barrett's oesophagus.
Cook MB, Wild CP, Everett SM, Hardie LJ, Bani-Hani KE, Martin IG, Forman D. Cook MB, et al. Aliment Pharmacol Ther. 2008 May;27(9):852-3; author reply 853-4. doi: 10.1111/j.1365-2036.2008.03645.x. Aliment Pharmacol Ther. 2008. PMID: 18380800 No abstract available.
Similar articles
- Mortality in Barrett's oesophagus: results from a population based study.
Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RG, McCarron P, Gavin AT. Anderson LA, et al. Gut. 2003 Aug;52(8):1081-4. doi: 10.1136/gut.52.8.1081. Gut. 2003. PMID: 12865262 Free PMC article. - Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.
van der Burgh A, Dees J, Hop WC, van Blankenstein M. van der Burgh A, et al. Gut. 1996 Jul;39(1):5-8. doi: 10.1136/gut.39.1.5. Gut. 1996. PMID: 8881798 Free PMC article. - Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N. Garside R, et al. Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080. Health Technol Assess. 2006. PMID: 16545207 Review. - Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort.
Cook MB, Coburn SB, Lam JR, Taylor PR, Schneider JL, Corley DA. Cook MB, et al. Gut. 2018 Mar;67(3):418-529. doi: 10.1136/gutjnl-2016-312223. Epub 2017 Jan 4. Gut. 2018. PMID: 28053055 Free PMC article. - Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance.
Rana PS, Johnston DA. Rana PS, et al. Dis Esophagus. 2000;13(1):28-31. doi: 10.1046/j.1442-2050.2000.00069.x. Dis Esophagus. 2000. PMID: 11005328 Review.
Cited by
- Barrett esophagus and life expectancy: implications for screening?
Kuipers EJ. Kuipers EJ. Gastroenterol Hepatol (N Y). 2011 Oct;7(10):689-91. Gastroenterol Hepatol (N Y). 2011. PMID: 22298963 Free PMC article. No abstract available. - Management controversies in Barrett's oesophagus.
Max Almond L, Barr H. Max Almond L, et al. J Gastroenterol. 2014 Feb;49(2):195-205. doi: 10.1007/s00535-013-0816-z. Epub 2013 Jun 5. J Gastroenterol. 2014. PMID: 23736794 Review. - Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.
Kanno T, Moayyedi P. Kanno T, et al. Curr Gastroenterol Rep. 2019 Dec 5;21(12):65. doi: 10.1007/s11894-019-0732-3. Curr Gastroenterol Rep. 2019. PMID: 31807948 Review. - Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
Visrodia K, Iyer PG, Schleck CD, Zinsmeister AR, Katzka DA. Visrodia K, et al. Dig Dis Sci. 2016 Jan;61(1):158-67. doi: 10.1007/s10620-015-3697-6. Epub 2015 May 9. Dig Dis Sci. 2016. PMID: 25956705 Free PMC article. - Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Reid BJ, Li X, Galipeau PC, Vaughan TL. Reid BJ, et al. Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773. Nat Rev Cancer. 2010. PMID: 20094044 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical